Living with Rheumatic Mitral Stenosis and a Dilated Left Atrium

Rheumatic mitral stenosis is a serious heart condition that affects millions worldwide. It occurs when the mitral valve, which regulates blood flow between the left atrium and left ventricle, becomes narrowed due to rheumatic fever. This narrowing obstructs blood flow, causing the left atrium to dilate or enlarge. Above Video is showing Rheumatic Mitral Valve Stenosis with dilated LA.

Symptoms

People with rheumatic mitral stenosis and a dilated left atrium may experience:

- Shortness of breath (dyspnea) during physical activity or at rest
- Fatigue and weakness
- Swelling in the legs, ankles, and feet (edema)
- Palpitations or irregular heartbeats
- Coughing up blood or pink, frothy mucus

Diagnosis

Diagnosing rheumatic mitral stenosis involves:

- Physical examination and medical history
- Echocardiogram (ultrasound of the heart) to visualize the mitral valve and left atrium
- Electrocardiogram (ECG) to assess heart rhythm
- Chest X-ray to evaluate lung congestion

Treatment

Treatment focuses on managing symptoms, preventing complications, and repairing or replacing the damaged mitral valve:

- Medications to control symptoms, such as diuretics, beta blockers, and anticoagulants
- Balloon mitral valvuloplasty (BMV) to widen the narrowed valve
- Surgical mitral valve repair or replacement
- Anticoagulation therapy to prevent stroke

Lifestyle Changes

Making healthy lifestyle choices can help manage rheumatic mitral stenosis:

- Regular exercise, such as walking or swimming, to improve cardiovascular health
- A balanced diet low in salt, sugar, and unhealthy fats
- Stress reduction techniques, such as meditation or yoga
- Quitting smoking and limiting alcohol consumption
- Regular follow-up appointments with your healthcare provider

Prognosis

With proper treatment and lifestyle changes, people with rheumatic mitral stenosis can lead active and fulfilling lives. However, if left untreated, the condition can lead to serious complications, such as:

- Heart failure
- Stroke
- Pulmonary hypertension
- Atrial fibrillation

Early diagnosis and treatment are crucial to managing rheumatic mitral stenosis and preventing long-term damage.

Comments

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts. The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Dr. Usman's Cardiology Notes

Search This Blog